Frontline BioVentures
Overview
Frontline BioVentures is a China-based venture capital firm specializing in investments in innovative life science companies. The firm focuses on businesses within strategic life science and technology areas promoted by the Chinese government. Frontline BioVentures manages two funds: a RMB-denominated fund and a parallel USD fund, offering structural flexibility to best serve the needs of its portfolio companies. The firm's investment strategy encompasses various stages, including early-stage, Series A, Series B, growth, late-stage, and pre-IPO investments. Geographically, Frontline BioVentures focuses on China and the United States, with a particular emphasis on sectors such as biotechnology, healthcare, medical devices, and pharmaceuticals. In May 2017, Frontline BioVentures merged with WuXi Healthcare Ventures to form 6 Dimensions Capital, a healthcare-focused investment group with extensive coverage across China and the U.S. This merger expanded the firm's portfolio and enhanced its capabilities in the life sciences sector.
Investment Focus
- Innovative life science companies
- Alignment with Chinese government-promoted strategic areas
- Potential for significant growth and market impact
Portfolio Companies
Reach Frontline BioVentures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Frontline BioVentures
What sectors does Frontline BioVentures invest in?
Frontline BioVentures invests in Healthcare, Pharmaceuticals, Medical Devices and Biotechnology, and is based in Shanghai, China. Frontline BioVentures is listed as a venture capital in the ConnectSafely investor database.
What stage does Frontline BioVentures invest at?
Frontline BioVentures backs companies at Early Stage, Series A, Series B, Growth, Late Stage and Pre-IPO.
Which regions does Frontline BioVentures invest in?
Frontline BioVentures invests across United States and China.
What companies has Frontline BioVentures invested in?
Frontline BioVentures's portfolio includes Hua Medicine, Innovent, BioKangtai, Yikon Genomics, Jiecheng Medical and Neusoft Medical.
How do I contact Frontline BioVentures?
Frontline BioVentures's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
